Stay updated with breaking news from Complete Response Letters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM, revenues increased 7%First quarter 2024 Dupixent® global net sales increased 24% to...
/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists' perceptions and...
Starting April 1, 2023, the U.S. Food and Drug Administration (FDA) will begin accepting requests to participate in a new Chemistry, Manufacturing, and Controls (CMC) Development and...
Starting April 1, 2023, the U.S. Food and Drug Administration (FDA) will begin accepting requests to participate in a new Chemistry, Manufacturing…
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... | August 9, 2022